AstraZeneca has made further headway in the race with larger competitor GlaxoSmi...
FILE PHOTO: Logo of AstraZeneca is displayed on a screen on the floor at the New York Stock Exchange in New York, U.S., April 8, 2019. REUTERS/Brendan McDermid/File Photo
Astra said on Wednesday its Lynparza drug, which blocks a cancer’s ability to repair its genetic code during cell division, was shown to slow the progression of ovarian cancer that has started to spread in the body. Those patients then normally receive Avastin as maintenance therapy to reinforce the initial regime and the study’s aim was to show an advantage of adding Lynparza during the follow-up phase.
Brasil Últimas Notícias, Brasil Manchetes
Similar News:Você também pode ler notícias semelhantes a esta que coletamos de outras fontes de notícias.
Kremlin says it is winning arms race against U.S. despite rocket accidentThe Kremlin boasted on Tuesday it was winning the race to develop new cutting ed...
Consulte Mais informação »
U.S. Fencer Reveals Mom's Inspiration For Anti-Trump Podium ProtestRace Imboden took a knee during a gold medal-winning ceremony at the Pan American Games after reading a social media post from his mom.
Consulte Mais informação »
There's No Reason to Buy Greek Yogurt AnymoreThis ultra-creamy Middle Eastern treat puts Greek yogurt to shame.
Consulte Mais informação »
A $1500 Halloween Advent Calendar Exists, and the Addams Family Needs to Get on My LevelWhat's Halloween without an advent calendar shaped like a spooky Victorian mansion? It's only . . . $1500! 😮🦇
Consulte Mais informação »
Hot mango summerSpicy, sweet and sour mangonada bars are the summertime treat you never knew you needed.
Consulte Mais informação »
5 foods to start eating now if you want to live a longer lifeWhat we eat and drink can impact our likelihood of dying from cancer and heart disease
Consulte Mais informação »